Virginia Retirement Systems Trims Healthpeak Properties Stake by 84.8%, Sells 647,400 Shares
Virginia Retirement Systems reduced its Healthpeak Properties stake by 84.8% in Q3, selling 647,400 shares. The institutional investor now holds 115,940 shares valued at $2.22 million, according to the latest SEC filing.
1. Major Stake Reduction by Virginia Retirement Systems
In the third quarter, Virginia Retirement Systems et al. reduced its position in Healthpeak Properties by 84.8%, selling 647,400 shares and retaining just 115,940 shares as disclosed in its latest SEC filing. The remaining stake was valued at approximately $2.22 million at quarter-end, marking one of the largest single-investor exits from the REIT during the period and signaling a significant shift in sentiment among large public pension funds.
2. Other Institutional Moves and Ownership Concentration
Several smaller institutional and hedge fund investors initiated or increased positions in Healthpeak Properties over the summer. Rexford Capital, Sound Income Strategies, Elevation Point Wealth Partners, CYBER HORNET ETFs and AlphaQuest each added stakes valued between $28,000 and $34,000 in the second and third quarters. Despite the Virginia Retirement Systems reduction, institutional and hedge fund ownership remains high at 93.57%, underscoring continued professional interest in the company’s specialized healthcare real estate portfolio.
3. Third-Quarter Financial Performance and FY2025 Guidance
Healthpeak Properties reported third-quarter revenue of $705.87 million, exceeding consensus estimates of $681.65 million and representing a 0.8% increase year-over-year. EPS came in at $0.46, topping the $0.45 forecast, although the REIT posted a negative net margin of 1.36% and a return on equity of -0.44%. Management set full-year 2025 EPS guidance in a range of 1.81 to 1.87, closely aligned with the street consensus of 1.86, reflecting confidence in ongoing leasing momentum in lab and medical office segments.
4. Dividend Policy and Analyst Consensus
On December 30th, Healthpeak paid a monthly dividend of $0.1017 per share to holders of record on December 19th, translating into a 7.5% yield on an annualized basis. The dividend payout ratio remains atypical at -2,440%, reflecting the temporary disconnect between distribution policy and net income. A dozen analyst reports issued since September span ratings from Hold to Outperform, with an average “Moderate Buy” consensus and a mean price target of $20.18, indicating expectations for modest upside relative to recent trading levels.